Pluspunten
Company is pursuing the right science and has been the last few years; seeks/desires to provide employees with tools, processes to perform their work effectively; endeavors to be transparent with people about the challenges and issues facing the company short-term; speaks of 'empowering' people though follow through on that is hit-and-miss; for the most part, people are committed to their work and delivering on objectives to what are sometimes difficult timelines which compromises that sacred work-life balance that is broadly promoted because of resources are lacking
Minpunten
Zero job security for US employees (non-Oncology, non-Biologics), the recurring and shortening cycle of downsizing has taken a toll on morale. Compounds coming through pipeline are promising, but not necessarily first-in-class presenting uptake challenges for commercialization. The headcount reductions have left those remaining with implicit expectations to manage/deliver with less resources. Headcount reductions have resulted in valued employees being cut due to 'strategic realignment'; dead wood was trimmed long ago, it's now trimming 'green branches on the tree' - leadership probably would not prefer such options, but it is a sign of the breadth and depth of the financial issues the company faces in order to deliver on financial objectives for shareholders.